Plant ID: NPO7395
Plant Latin Name: Tribulus terrestris
Taxonomy Genus: Tribulus
Taxonomy Family: Zygophyllaceae
NCBI TaxonomyDB:
210369
Plant-of-the-World-Online:
n.a.
Abortifacient; Alterative; Anthelmintic; Aphrodisiac; Carminative; Demulcent; Diuretic; Galactogogue; Infertility; Pectoral
India; China; Algeria
ADRA2C; | |
DYRK2; DYRK3; CLK1; DYRK1A; DYRK1B; HASPIN; | |
MAOA; | |
MAPT; LMNA; |
Cytochrome P450 Enzymes: | CYP1A2; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Oxidoreductase | MAOA | Monoamine oxidase A | P21397 | CHEMBL1951 |
Protein Kinase | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | Q92630 | CHEMBL4376 |
Protein Kinase | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | O43781 | CHEMBL4575 |
Protein Kinase | CLK1 | Dual specificty protein kinase CLK1 | P49759 | CHEMBL4224 |
Protein Kinase | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Q13627 | CHEMBL2292 |
Protein Kinase | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Q9Y463 | CHEMBL5543 |
Protein Kinase | HASPIN | Serine/threonine-protein kinase haspin | Q8TF76 | CHEMBL1075163 |
Small molecule receptor (family A GPCR) | ADRA2C | Alpha-2c adrenergic receptor | P18825 | CHEMBL1916 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004712; protein serine/threonine/tyrosine kinase activity | 1.738E-11 | 3.785E-07 | CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
BP | GO:0008152; metabolic process | GO:0018108; peptidyl-tyrosine phosphorylation | 3.458E-08 | 2.040E-04 | CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
MF | GO:0003824; catalytic activity | GO:0004713; protein tyrosine kinase activity | 3.017E-08 | 2.040E-04 | CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
MF | GO:0003824; catalytic activity | GO:0004674; protein serine/threonine kinase activity | 6.732E-08 | 2.932E-04 | CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, HASPIN |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 2.121E-04 | 5.938E-03 | MAOA, CYP1A2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 6.323E-04 | 8.853E-03 | MAOA, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
S00-T88: Injury, poisoning and certain other consequences of external causes | Contusion | S36.220S | ADRA2C; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Fibromyalgia | M79.7 | ADRA2C; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poison intoxication | T36-T50 | ADRA2C; |
I00-I99: Diseases of the circulatory system | Hypotension | I95 | ADRA2C; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | ADRA2C; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Male sexual disorders | F52 | ADRA2C; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | MAOA; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | ADRA2C; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | ADRA2C; |
L00-L99: Diseases of the skin and subcutaneous tissue | Erythema | L51-L54 | ADRA2C; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | ADRA2C; MAOA; MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | MAOA; |
J00-J99: Diseases of the respiratory system | Allergic rhinitis | J00, J30, J31.0, T78.4 | ADRA2C; |
K00-K95: Diseases of the digestive system | Peptic ulcer | K25-K27 | ADRA2C; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | ADRA2C; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | ADRA2C; MAOA; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic nephropathy | E11.21 | ADRA2C; |
L00-L99: Diseases of the skin and subcutaneous tissue | Vitiligo | L80 | MAOA; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | ADRA2C; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | ADRA2C; MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | MAOA; |
I00-I99: Diseases of the circulatory system | Hypertension | I10-I16 | ADRA2C; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ADRA2C; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mood disorder | F30-F39 | MAOA; |
H00-H59: Diseases of the eye and adnexa | Ocular disease | H00-H59 | ADRA2C; |